Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi
Author(s) -
Leonardo Palombi,
Maria Franca Pirillo,
Emilia Marchei,
Haswell Jere,
JeanBaptiste Sagno,
Richard Luhanga,
Marco Floridia,
Mauro Andreotti,
Clementina Maria Galluzzo,
Simona Pichini,
Ruben Mwenda,
S Mancinelli,
Maria Cristina Marazzi,
Stefano Vella,
Giuseppe Liotta,
Marina Giuliano
Publication year - 2015
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkv435
Subject(s) - efavirenz , lamivudine , breastfeeding , breast milk , medicine , breast feeding , obstetrics , pregnancy , viral load , tenofovir , human immunodeficiency virus (hiv) , antiretroviral therapy , pediatrics , virology , virus , biology , hepatitis b virus , biochemistry , genetics
To evaluate antiretroviral drug concentrations in mothers and infants enrolled under the Option B-Plus approach for the prevention of HIV mother-to-child transmission in Malawi and to assess the maternal virological response after 1 year of treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom